Amylyx Pharmaceuticals, Inc. (AMLX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $138.0K | -12.1% |
| 2024 | $157.0K | -87.3% |
| 2023 | $1.24M | -50.9% |
| 2022 | $2.53M | +615.6% |
| 2021 | $353.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $138.0K | -12.1% |
| 2024 | $157.0K | -87.3% |
| 2023 | $1.24M | -50.9% |
| 2022 | $2.53M | +615.6% |
| 2021 | $353.0K | — |